AAK AB (0A0J)
London Exchange · UK · prices in SEK · close of 23 Oct 2026
Key indicators
| Last close | SEK 179.85 |
|---|---|
| 52-week range | 179.85 – 277.00 |
| Return, 1 month / 3 months | −1.0% / −9.1% |
| Return, 1 year / 3 years | −31.7% / −6.6% |
| Trend | Below its 200-day average |
| RSI (14) | 35 |
| Volatility (1 year) | 27.1% |
| Worst drawdown (1 year) | -33.3% |
| Average daily value traded | 21.57M SEK |
| Dividend yield | 3.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
AAK AB is a Swedish company that makes and supplies vegetable oils and fats, based in Malmö. It produces specialty fats and oils used by food manufacturers, including cocoa butter equivalents and other plant-based ingredients for chocolate, confectionery, bakery and dairy products. Its customers are mainly food producers and industrial bakeries that use these fats as ingredients, and the company also serves the cosmetics and personal care sector with plant-based oils.
On this site AAK AB appears as a stock on the London Exchange (UK), code 0A0J, with prices in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
AAK AB (0A0J) trades on the London Exchange in UK. It last closed at SEK 179.85 on 23 October 2026.
Its price-based Market X-Ray is 40 out of 100 (a weak price profile), ranking 2,646 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 31.7% and over the last three months it fell 9.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 18 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -20.2% | ||
| From 52-week high | -34.7% | ||
| Momentum | 19 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -9.1% | ||
| 6-month return | -26.0% | ||
| 12-month return, skipping the last month | -31.1% | ||
| Stability (higher is calmer) | 56 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 27.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -33.3% | ||
| Liquidity | 80 · Strong | Trades actively. | |
| Average daily value traded | 21.57M SEK | ||
| Zero-volume days | 6.7% | ||
| Income | 47 · Weak | Dividend is small or irregular. | |
| Dividend yield | 3.1% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Income: Dividend is small or irregular.
Returns
| 1 week | −6.0% |
|---|---|
| 1 month | −1.0% |
| 3 months | −9.1% |
| 6 months | −26.0% |
| 1 year | −31.7% |
| 3 years | −6.6% |
| 5 years | +4.4% |
Signals
| 50-day / 200-day average | 192.70 / 225.45 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 4.33 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 11 May 2026 | SEK 5.5000 |
| 9 May 2025 | SEK 5.0000 |
| 10 May 2024 | SEK 3.7000 |
| 5 May 2023 | SEK 2.7500 |
| 19 May 2022 | SEK 2.5000 |
| 10 May 2021 | SEK 2.3000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.